Fallopian Tube Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials

Bevacizumab Plus Modified FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma, Single-arm, Phase II Study
Conditions:   Mucinous Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer Intervention:   Drug: Bevacizumab + modified FOLFIRINOX Sponsor:   Yonsei University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 26, 2022 Category: Research Source Type: clinical trials

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Conditions:   Stage III Ovarian Cancer;   Stage IV Ovarian Cancer;   Stage III Primary Peritoneal Cancer;   Stage IV Primary Peritoneal Cancer;   Stage III Fallopian Tube Cancer;   Stage IV Fallopian Tube Cancer Interventions:   Drug: Cisplatin;   Other: No treatment Sponsors:   GOG Foundation;   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2022 Category: Research Source Type: clinical trials